Study of EOC317 in Chinese Patients With Advanced Solid Tumors
NCT03583125
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
140
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
EOC317
Sponsor
Taizhou EOC Pharma Co., Ltd.